Prevention of diabetes-induced cardiovascular complications upon treatment with antioxidants

被引:0
|
作者
Yan-Jun Xu
Paramjit S. Tappia
Nirankar S. Neki
Naranjan S. Dhalla
机构
[1] St. Boniface Hospital Research,Department of Physiology, Institute of Cardiovascular Sciences, Faculty of Medicine, University of Manitoba
[2] St. Boniface Hospital Research,Asper Clinical Research Institute
来源
Heart Failure Reviews | 2014年 / 19卷
关键词
Oxidative stress; Atherosclerosis; Resveratrol; Cardiovascular disease; Diabetes; Antioxidants;
D O I
暂无
中图分类号
学科分类号
摘要
Oxidative stress is considered to play an important role in the pathogenesis of diabetes-induced cardiovascular disease (CVD), which is invariably associated with abnormal blood lipid profile, insulin resistance and metabolic syndrome. Stress, smoking, high saturated fat intake as well as low fruit and vegetable intakes have been shown to increase oxidative stress and hyperlipidemia, which increase the predisposition of diabetic subjects to atherosclerosis, stroke and coronary heart disease. The oxidation of low-density lipoprotein by oxidative stress is essential for the development of atherosclerosis, and the reduction in oxidative stress as well as blood glucose and cholesterol is considered critical for the prevention of diabetes-induced CVD. Although epidemiological studies have demonstrated that vitamin C and vitamin E decrease the incidence of coronary heart disease, different clinical trials have failed to support the beneficial effect of these antioxidants. Nonetheless, it has been suggested that natural forms of these vitamins may be more efficacious than synthetic vitamins, and this may explain the inconsistencies in results. Antioxidants, N-acetyl-l-cysteine and resveratrol, have also been shown to attenuate the diabetes-induced cardiovascular complications. It has been indicated that the antioxidant therapy may be effective in a prevention strategy rather than as a treatment for CVD. The evidence presented here supports the view that cardiovascular complications in diabetes may be induced by oxidative stress and appropriate antioxidant therapy may be promising for attenuating the progression of diabetes-induced CVD.
引用
收藏
页码:113 / 121
页数:8
相关论文
共 50 条
  • [41] DIABETES-INDUCED CHANGES IN THE CARDIOVASCULAR-SYSTEM OF THE STREPTOZOTOCIN DIABETIC RAT
    PFAFFMAN, MA
    HILMAN, R
    DARBY, A
    FEDERATION PROCEEDINGS, 1981, 40 (03) : 740 - 740
  • [42] Prevention of diabetes-induced microangiopathy by human tissue kallikrein gene therapy
    Madeddu, P
    Salis, MB
    Stacca, T
    Milia, AF
    Pinna, A
    Gaspa, L
    Chao, J
    Chao, J
    Chao, L
    Emanueli, C
    CIRCULATION, 2001, 104 (17) : 138 - 139
  • [43] Prevention and treatment of diabetes and its complications - Preface
    Skyler, JS
    MEDICAL CLINICS OF NORTH AMERICA, 1998, 82 (04) : XI - XII
  • [44] Prevention and treatment of microvascular and neuropathic complications of diabetes
    Eastman, RC
    Garfield, SA
    PRIMARY CARE, 1999, 26 (04): : 791 - +
  • [45] PREVENTION AND TREATMENT OF THE COMPLICATIONS OF DIABETES-MELLITUS
    KLEIN, M
    NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (12): : 802 - 802
  • [46] PREVENTION AND TREATMENT OF THE COMPLICATIONS OF DIABETES-MELLITUS
    CLARK, CM
    LEE, DA
    NEW ENGLAND JOURNAL OF MEDICINE, 1995, 332 (18): : 1210 - 1217
  • [47] Prevention of diabetes-induced microangiopathy by human tissue kallikrein gene transfer
    Emanueli, C
    Salis, MB
    Pinna, A
    Stacca, T
    Milia, AF
    Spano, A
    Chao, J
    Chao, L
    Sciola, L
    Madeddu, P
    CIRCULATION, 2002, 106 (08) : 993 - 999
  • [48] How to ADVANCE prevention of cardiovascular complications in type 2 diabetes
    Grobbee, DE
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2003, 52 (08): : 24 - 28
  • [49] Diabetes Diabetes-induced microvascular destabilization
    Huynh, Karina
    NATURE REVIEWS CARDIOLOGY, 2017, 14 (03) : 129 - 129
  • [50] Anti-CTGFantibody therapy with FG-3019 reverses diabetes-induced cardiovascular complications in streptozotocin (STZ) treated rats
    Langsetmo, Ingrid
    Jacob, Christopher
    Zhang, Weihua
    Oliver, Noelynn
    Lin, Al
    Coker, George
    Liu, David
    DIABETES, 2006, 55 : A122 - A122